Composition containing linezolid as well as preparation method thereof

A technology of linezolid and a composition is applied in the field of linezolid tablets and preparation thereof, and can solve the problems of linezolid being easy to change crystal form, poor solubility, immiscibility and the like, and achieves simple production process operation and low cost. Effect

Inactive Publication Date: 2015-05-06
HANGZHOU HUADONG MEDICINE GRP PHARMA RES INST
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0015] The purpose of the present invention is to overcome the technical defects of linezolid in the existing process, such as easy crystal transformation, incompatibility, and poor solubility, and to provide a stable, good dissolution, simple operation, low cost, and efficient preparation. process to suit industrialized mass production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition containing linezolid as well as preparation method thereof
  • Composition containing linezolid as well as preparation method thereof
  • Composition containing linezolid as well as preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1-7

[0043] Example 1-7: Preparation prescription dosage

[0044]

[0045] Process:

[0046](1) Pulverize linezolid, with an average particle size of ≤107 μm, d90 ≤ 243 μm, and d50 ≤ 56 μm;

[0047] (2) Mix linezolid, sodium lauryl sulfate, crospovidone internally added, copovidone S-630, anhydrous citric acid internally added, and sodium bicarbonate internally, and dry granulator granulation;

[0048] (3) Add starch lactose, crospovidone extra part, anhydrous citric acid extra part, sodium bicarbonate extra part, magnesium stearate, silicon dioxide, and mix well;

[0049] (4) Conventional method tabletting;

[0050] (5) Pack 2 layers of coatings. For the first time, 80% copovidone S-630 and 20% ethylcellulose are prepared to a concentration of 10% with ethanol, and the weight gain of the coating is 0.8-1.2%; Generation (295F680001WHITE) was prepared with 80% ethanol solution to a concentration of 8%, and the coating weight increased by 1%-2%.

[0051] For the above example...

Embodiment 8-12

[0055] Embodiment 8-12: the comparative test of anhydrous citric acid, sodium bicarbonate adding total amount and adding method

[0056]

Example 8

Example 9

Example 10

Example 11

Example 12

Linezolid

600

600

600

600

600

Sodium dodecyl sulfate

10

10

10

10

10

Copovidone

40

40

40

40

40

starch lactose

80

80

80

80

80

Added crospovidone

40

40

40

40

40

Crospovidone Plus

10

10

10

10

10

Added anhydrous citric acid

30

0

7

5

4

Anhydrous citric acid plus

0

30

3.5

2.5

2

Added sodium bicarbonate

30

0

7

5

4

Sodium bicarbonate plus

0

30

3.5

2.5

2

Magnesium stearate

5

5

5

5

5

silica

25

25

25

25

25

production

1000 pieces

1000 piece...

Embodiment 13-18

[0061] Embodiment 13-18: Determination of sodium bicarbonate, anhydrous citric acid internal / external addition ratio

[0062] prescription:

[0063]

[0064] Technology: with embodiment 1.

[0065] According to Chinese Pharmacopoeia 2010 edition two appendix V D high performance liquid chromatography in 0.1NHCl, pH4.5 acetate buffer solution, purified water, the 15-minute dissolution rate (%) of prescription 13-18 is detected in phosphate buffer solution.

[0066]

[0067] The results show that when sodium bicarbonate and anhydrous citric acid are added / externally added to be greater than 4 or less than 0.5, the dissolution rate in 15 minutes is unqualified.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
The average particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a composition containing linezolid. The compositoion consists of linezolid, sodium lauryl sulfate, copovidone, starch lactose, crospovidone, anhydrous citric acid, sodium bicarbonate, magnesium stearate and silicon dioxide. The invention further discloses a method for preparing the composition containing linezolid. The problems that linezolid is poor in solubility and the like are solved by adopting dry granulating, adding anhydrous citric acid and sodium bicarbonate as an effervescing agent, controlling the proportion of internal addition and external addition and the like. The composition containing linezolid is particularly stable in quality and good in solubility, so that the product quality is greatly improved. The preparation method disclosed by the invention is simple to operate, low in cost and quite suitable for industrial production.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a linezolid tablet and a preparation method thereof. Background technique [0002] Linezolid, a synthetic oxazolidinone antibiotic, was approved by the US FDA in 2000 for the treatment of infections caused by Gram-positive (G+) cocci, including suspected or confirmed hospital-acquired pneumonia (HAP) caused by MRSA, Community-acquired pneumonia (CAP), complicated skin or skin and soft tissue infection (SSTI), and vancomycin-resistant enterococci (VRE) infection. [0003] Linezolid is a bacterial protein synthesis inhibitor that acts on the bacterial 50S ribosomal subunit and is closest to the site of action. Unlike other drugs, linezolid does not affect the activity of peptidyl transferase, but only acts on the initial stage of the translation system, inhibits the connection between mRNA and ribosomes, prevents the formation of the 70S initiation complex, and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/44A61K31/5377A61K47/02A61K47/12A61P31/04
Inventor卢良华
OwnerHANGZHOU HUADONG MEDICINE GRP PHARMA RES INST